Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Ravi Chandra Babu"'
Autor:
Chennuru, Ramanaiah, Muthudoss, Prakash, Ramakrishnan, Srividya, Mohammad, Amjad Basha, Ravi Chandra Babu, R., Mahapatra, Sudarshan, Nayak, Susanta K.
Publikováno v:
In Journal of Molecular Structure 15 September 2016 1120:86-99
Autor:
Bhavana D., Sirisha J., Sumesh M. A., G., Ravi Chandra Babu, Maji, Amit, Karanth, S. P., Sriram K. V.
Publikováno v:
Indian Journal of Pure & Applied Physics; Feb2023, Vol. 61 Issue 2, p85-89, 5p
Publikováno v:
INCOSE International Symposium. 29:86-98
Autor:
Ramanaiah Chennuru, Balaji Maddimsetti, Suman Gundlapalli, R. Ravi Chandra Babu, Sudarshan Mahapatra
Publikováno v:
Acta Crystallographica Section E: Crystallographic Communications, Vol 71, Iss 8, Pp o615-o616 (2015)
In the title compound, C11H6BrClO3, the benzopyran ring system is essentially planar, with a maximum deviation of 0.036 (2) Å for the O atom. The Cl and Br atoms are displaced by −0.0526 (8) and 0.6698 (3) Å, respectively, from the mean plane of
Externí odkaz:
https://doaj.org/article/d12a8852d80c4d6ca0291cc1beed3d00
Publikováno v:
Incose International Symposium; Dec2019 Supplement, Vol. 29 Issue 1, p86-98, 13p
Autor:
Saladi Venkata Narasayya, Sudarshan Mahapatra, Prakash Muthudoss, Pavan Kommavarapu, Ravi Teja Koya, R. Ravi Chandra Babu, Ramanaiah Chennuru, Peddy Vishweshwar
Publikováno v:
Crystal Growth & Design. 17:6341-6352
Ceritinib is an anaplastic lymphoma kinase (ALK) inhibitor used for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC). This BCS class IV drug is developed by Novartis and traded under the name Zykadia. To date two forms [For
Autor:
Ravi Chandra Babu
Publikováno v:
World Journal of Pharmacy and Pharmaceutical Sciences. :1353-1371
Publikováno v:
Asian Journal of Chemistry. 29:2249-2253
Autor:
Sudarshan Mahapatra, R. Ravi Chandra Babu, Prakash Muthudoss, Raja Sekhar Voguri, Ramanaiah Chennuru, Srividya Ramakrishnan, Peddy Vishweshwar
Publikováno v:
Crystal Growth & Design. 17:612-628
Lenalidomide (LDM) is a thalidomide analogue known for its immunomodulation, antiangiogenic, and antineoplastic properties. However, to date, only two forms of lenalidomide [Form-1 (anhydrous) and Form-2 (hemihydrate)] are reported in the literature.
Autor:
Sudarshan Mahapatra, Amjad Basha Mohammad, Ramanaiah Chennuru, Prakash Muthudoss, Srividya Ramakrishnan, R. Ravi Chandra Babu, Susanta K. Nayak
Publikováno v:
Journal of Molecular Structure. 1120:86-99
Two polymorphs Form-R2 and Form-R4 of anhydrous thymine, one of the four nucleobases in the nucleic acid of DNA were obtained via sublimation crystallization and desolvation technique respectively. Form-R2 crystallizes in monoclinic C 2/c with a = 25